Contract 75N95022P00365
Mimetas Operations Us, Co. · Department Of Health And Human Services · July 22, 2022
Mimetas Operations Us, Co. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on July 22, 2022 for $150,000 of work in biological product (except diagnostic) manufacturing. Performance is in Gaithersburg, MD. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 20, 2024.
Contract details
- PIID
- 75N95022P00365
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Gaithersburg, MD
- First action
- July 22, 2022
- Latest action
- September 20, 2024
Description
ACQUISITION OF ORGANOPLATE GRAFT TO BE USED FOR SARS_COV-2 PROJECT
Modification timeline
-
September 20, 2024Mod P00002$-33.3K
-
March 10, 2023Mod P00001$0
-
July 22, 2022Base award$183.7K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N95022P00365?
Contract 75N95022P00365 is a federal contract awarded to Mimetas Operations Us, Co. by Department Of Health And Human Services on July 22, 2022 for $150,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 75N95022P00365?
Mimetas Operations Us, Co. won contract 75N95022P00365 from Department Of Health And Human Services.
How much is contract 75N95022P00365 worth?
Contract 75N95022P00365 has obligated $150,000 to date.